(NASDAQ: AZTA) Azenta's forecast annual revenue growth rate of 6.44% is not forecast to beat the US Medical Instruments & Supplies industry's average forecast revenue growth rate of 12.1%, and while it is not forecast to beat the US market's average forecast revenue growth rate of 17.26%.
Azenta's revenue in 2026 is $594,953,000.On average, 10 Wall Street analysts forecast AZTA's revenue for 2026 to be $29,263,349,989, with the lowest AZTA revenue forecast at $27,616,650,327, and the highest AZTA revenue forecast at $30,421,336,828. On average, 10 Wall Street analysts forecast AZTA's revenue for 2027 to be $31,014,609,322, with the lowest AZTA revenue forecast at $29,124,704,787, and the highest AZTA revenue forecast at $32,912,344,316.
In 2028, AZTA is forecast to generate $32,870,428,325 in revenue, with the lowest revenue forecast at $30,167,077,188 and the highest revenue forecast at $35,499,620,400.